110 / 119
109
Diretrizes AMB
26. Gordon KB, Langley RG, Leonardi C, Toth D, Menter MA, Kang S,
Heffernan M, Miller B, Hamlin R, Lim L, Zhong J, Hoffman R, Okun
MM. Clinical response to adalimumab treatment in patients with
moderate to severe psoriasis: double-blind, randomized controlled trial
and open-label extension study. J Am Acad Dermatol. 2006 Oct;55(4):598-
606. Epub 2006 Aug 10. PubMed PMID: 17010738.
27. Kimball AB, Papp KA, Wasfi Y, Chan D, Bissonnette R, Sofen H, Yeilding
N, Li S, Szapary P, Gordon KB; PHOENIX 1 Investigators. Long-term
efficacy of ustekinumab in patients with moderate-to-severe psoriasis